TwinStrand Biosciences Inc, based in Seattle, WA, is a leading biotechnology company specializing in high-resolution DNA sequencing technology. Their flagship product, TwinStrand Duplex Sequencing, offers a revolutionary approach to next-generation sequencing, reducing error rates and revealing hidden data by independently tracking both strands of individual DNA molecules. With applications in measurable residual disease detection, mutation signatures, and variant identification, TwinStrand Duplex Sequencing provides researchers with unparalleled accuracy and resolution beyond standard NGS methods. Through a combination of proprietary biochemistry and cloud-based informatics, TwinStrand Biosciences is at the forefront of advancing mutagenesis testing and genomic research. Their technology has been validated in collaboration with renowned institutions such as Health Canada, demonstrating its potential to overcome limitations in current mutagenicity assays and provide novel insights into the mutagenic mode of action. With a commitment to scientific collaboration and innovation, TwinStrand Biosciences is revolutionizing the field of DNA sequencing and empowering researchers to unlock the full potential of genetic analysis.Generated from the website